Vivos Therapeutics Agrees Debt for Equity Deal With Streeterville Capital

MT Newswires Live06-05

Vivos Therapeutics (VVOS) entered a deal with its senior, secured lender, Streeterville Capital to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares, the company said Friday.

The agreement includes commitments by Streeterville to suspend any calls for repayment of its debt and any sales of company securities for 90 and 60 days, respectively, from the date the deal becomes effective, the company said.

The conversion of Streeterville's debt into equity is meant to advance shareholders' positions and comply with Nasdaq listing standards, the company said.

Shares of the company were up 5.1% in recent premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2641435191?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2641435191","market":"hk","top_or_hot":-1,"title":"Vivos Therapeutics Agrees Debt for Equity Deal With Streeterville Capital","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> (VVOS) entered a deal with its senior, secured lender, Streeterville Capital to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares, the company said Friday.</p><p>The agreement includes commitments by Streeterville to suspend any calls for repayment of its debt and any sales of company securities for 90 and 60 days, respectively, from the date the deal becomes effective, the company said.</p><p>The conversion of Streeterville's debt into equity is meant to advance shareholders' positions and comply with Nasdaq listing standards, the company said.</p><p>Shares of the company were up 5.1% in recent premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivos Therapeutics Agrees Debt for Equity Deal With Streeterville Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivos Therapeutics Agrees Debt for Equity Deal With Streeterville Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-05 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> (VVOS) entered a deal with its senior, secured lender, Streeterville Capital to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares, the company said Friday.</p><p>The agreement includes commitments by Streeterville to suspend any calls for repayment of its debt and any sales of company securities for 90 and 60 days, respectively, from the date the deal becomes effective, the company said.</p><p>The conversion of Streeterville's debt into equity is meant to advance shareholders' positions and comply with Nasdaq listing standards, the company said.</p><p>Shares of the company were up 5.1% in recent premarket activity.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EQR","symbol_name":"资产住宅公司","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2641435191","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2641435191","pubTimestamp":1780664610,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vivos Therapeutics  entered a deal with its senior, secured lender, Streeterville Capital to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares, the company said Friday.The agreement includes commitments by Streeterville to suspend any calls for repayment of its debt and any sales of company securities for 90 and 60 days, respectively, from the date the deal becomes effective, the company said.The conversion of Streeterville's debt into equity is meant to advance shareholders' positions and comply with Nasdaq listing standards, the company said.Shares of the company were up 5.1% in recent premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EQR":"资产住宅公司","BK4215":"住宅房地产投资信托","VVOS":"Vivos Therapeutics","BK4588":"碎股","BK4196":"保健护理服务","BK4585":"ETF&股票定投概念"},"translate_title":"Vivos Therapeutics同意与Streeterville Capital进行债转股交易","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EQR":1.5,"VVOS":1.5},"content_text":"Vivos Therapeutics (VVOS) entered a deal with its senior, secured lender, Streeterville Capital to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares, the company said Friday.The agreement includes commitments by Streeterville to suspend any calls for repayment of its debt and any sales of company securities for 90 and 60 days, respectively, from the date the deal becomes effective, the company said.The conversion of Streeterville's debt into equity is meant to advance shareholders' positions and comply with Nasdaq listing standards, the company said.Shares of the company were up 5.1% in recent premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2641435191","isCrawlerRequest":true}